Pacira BioSciences (PCRX)
22.67
+0.35 (1.57%)
Upcoming Events
Latest Headlines
Form DEFA14A Pacira BioSciences, Inc.
June 4, 2026 4:24 PM - SEC Filing
Pacira BioSciences urges stockholders to vote for company nominees
June 4, 2026 4:21 PM - StreetInsider
Pacira BioSciences Reminds Stockholders to Vote the BLUE Proxy Card "FOR" the Election of the Company's Highly Qualified Nominees Ahead of its Annual Meeting
June 4, 2026 4:20 PM - PR NewsWire
Form 144 Pacira BioSciences, Inc. Filed by: WILLIAMS KRISTEN
June 4, 2026 9:49 AM - SEC Filing
Form DEFA14A Pacira BioSciences, Inc.
June 1, 2026 5:15 PM - SEC Filing
Pacira BioSciences Highlights Leading Independent Proxy Advisory Firm ISS' Recommendation to Vote "FOR" All of Pacira's Director Nominees
June 1, 2026 4:50 PM - PR NewsWire
PharmaCorp Rx Inc. Announces First Quarter 2026 Financial Results
June 1, 2026 9:00 AM - Globe NewsWire
Form DFAN14A Pacira BioSciences, Inc. Filed by: Doma Perpetual Capital Management LLC
May 28, 2026 5:52 PM - SEC Filing
Form DEFA14A Pacira BioSciences, Inc.
May 28, 2026 5:13 PM - SEC Filing
Glass Lewis backs Pacira BioSciences director nominees
May 28, 2026 4:41 PM - StreetInsider
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Pacira’s Director Nominees
May 28, 2026 4:20 PM - Globe NewsWire
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Pacira’s Director Nominees
May 28, 2026 4:20 PM - StreetInsider
DOMA PERPETUAL CAPITAL MANAGEMENT QUESTIONS WHY SHAREHOLDERS SHOULD VOTE TO CONTINUE WITH A BOARD THAT HAS OVERSEEN A DECADE OF VALUE DESTRUCTION
May 28, 2026 9:19 AM - PR NewsWire
Form DEFA14A Pacira BioSciences, Inc.
May 27, 2026 4:59 PM - SEC Filing
Pacira BioSciences urges shareholders to support board nominees
May 27, 2026 4:23 PM - StreetInsider
Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company’s Strategic Direction and Highly Qualified Nominees
May 27, 2026 4:20 PM - StreetInsider
After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
May 27, 2026 9:00 AM - StreetInsider
Pacira BioSciences reports study links EXPAREL to reduced opioid use
May 27, 2026 8:03 AM - StreetInsider
Pacira BioSciences Reports Real-World Study Showing EXPAREL® Use Was Associated with Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder Arthroplasty
May 27, 2026 8:00 AM - Globe NewsWire
Form DEFA14A Pacira BioSciences, Inc.
May 26, 2026 4:41 PM - SEC Filing
Pacira BioSciences defends patent strategy amid proxy fight
May 26, 2026 8:00 AM - StreetInsider
Pacira BioSciences Sets the Record Straight Regarding DOMA’s Misleading Statements About Pacira’s Intellectual Property Strategy
May 26, 2026 8:00 AM - StreetInsider
PharmaCorp to acquire Ontario pharmacy for $8.2 million
May 25, 2026 9:27 AM - StreetInsider
PharmaCorp Announces Definitive Agreement to Acquire PharmaChoice Canada Bannered Pharmacy in Ontario
May 25, 2026 9:27 AM - Globe NewsWire
A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching
May 22, 2026 10:09 AM - Globe NewsWire
Form DFAN14A Pacira BioSciences, Inc. Filed by: Doma Perpetual Capital Management LLC
May 21, 2026 5:09 PM - SEC Filing
A LETTER TO PACIRA BIOSCIENCES SHAREHOLDERS FROM DOMA PERPETUAL CAPITAL MANAGEMENT LLC
May 21, 2026 1:54 PM - PR NewsWire
Form DEFA14A Pacira BioSciences, Inc.
May 20, 2026 5:25 PM - SEC Filing
Form DFAN14A Pacira BioSciences, Inc. Filed by: Doma Perpetual Capital Management LLC
May 20, 2026 3:36 PM - SEC Filing
DOMA Perpetual Director Nominees Send Letter to Shareholders of Pacira Biosciences
May 20, 2026 12:28 PM - PR NewsWire
Pacira BioSciences urges shareholders to vote for board nominees
May 20, 2026 6:30 AM - StreetInsider
Pacira BioSciences Files Investor Presentation Highlighting Successful Execution of its Long-Term Strategy to Drive Value for All Stockholders
May 20, 2026 6:30 AM - Globe NewsWire
Form DEFA14A Pacira BioSciences, Inc.
May 20, 2026 6:02 AM - SEC Filing
Form DEFA14A Pacira BioSciences, Inc.
May 13, 2026 4:04 PM - SEC Filing
Form DFAN14A Pacira BioSciences, Inc. Filed by: Doma Perpetual Capital Management LLC
May 13, 2026 1:54 PM - SEC Filing
DOMA Perpetual launches proxy fight for three Pacira BioSciences board seats
May 13, 2026 11:00 AM - StreetInsider
DOMA Perpetual Issues & Mails Letter to Shareholders of Pacira BioSciences - Along with its Definitive Proxy Statement & WHITE Proxy Card - Urging Shareholders to Vote "FOR" DOMA's T
May 13, 2026 10:59 AM - PR NewsWire
Pacira BioSciences to Participate in Fireside Chats at Three Upcoming Healthcare Conferences
May 13, 2026 8:00 AM - Globe NewsWire
Form DEFC14A Pacira BioSciences, Inc. Filed by: Doma Perpetual Capital Management LLC
May 12, 2026 5:24 PM - SEC Filing
Form DFAN14A Pacira BioSciences, Inc. Filed by: Doma Perpetual Capital Management LLC
May 12, 2026 4:10 PM - SEC Filing
Form DEFA14A Pacira BioSciences, Inc.
May 12, 2026 4:03 PM - SEC Filing
Pacira BioSciences urges stockholders to support board nominees
May 12, 2026 4:01 PM - StreetInsider
Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees
May 12, 2026 4:01 PM - StreetInsider
Form PRRN14A Pacira BioSciences, Inc. Filed by: Doma Perpetual Capital Management LLC
May 8, 2026 3:33 PM - SEC Filing
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 8, 2026 8:00 AM - Globe NewsWire
Form DEFA14A Pacira BioSciences, Inc.
May 5, 2026 4:23 PM - SEC Filing
Pacira BioSciences urges shareholders to vote for board nominees
May 5, 2026 4:20 PM - StreetInsider
Pacira BioSciences Mails Letter to Stockholders
May 5, 2026 4:20 PM - StreetInsider
PharmaCorp acquires pharmacy files in western Canada for $300,000
May 1, 2026 5:00 PM - StreetInsider
PharmaCorp Completes Acquisition of Pharmacy Files in Western Canada
May 1, 2026 5:00 PM - Globe NewsWire
Form SCHEDULE 13G Pacira BioSciences, Inc. Filed by: VANGUARD PORTFOLIO MANAGEMENT LLC
May 1, 2026 9:22 AM - SEC Filing
Form SCHEDULE 13G Pacira BioSciences, Inc. Filed by: VANGUARD CAPITAL MANAGEMENT LLC
May 1, 2026 9:13 AM - SEC Filing
Pacira Pharmaceuticals (PCRX) PT Raised to $32 at Needham
May 1, 2026 7:19 AM - StreetInsider
RBC Capital Reiterates Sector Perform Rating on Pacira Pharmaceuticals (PCRX)
May 1, 2026 4:18 AM - StreetInsider
Pacira Pharma (PCRX) Tops Q1 EPS by 4c, provides guidance
April 30, 2026 4:49 PM - StreetInsider
Form 10-Q Pacira BioSciences, Inc. For: Mar 31
April 30, 2026 4:13 PM - SEC Filing
Form 8-K Pacira BioSciences, Inc. For: Apr 30
April 30, 2026 4:05 PM - SEC Filing
Pacira BioSciences Reports First Quarter 2026 Financial Results
April 30, 2026 4:01 PM - StreetInsider
PharmaCorp to acquire eight pharmacies for $24.2 million
April 30, 2026 11:04 AM - StreetInsider
PharmaCorp to Acquire Eight Pharmacies and Provides Acquisition Pipeline Update
April 30, 2026 11:04 AM - Globe NewsWire
Form PRRN14A Pacira BioSciences, Inc. Filed by: Doma Perpetual Capital Management LLC
April 30, 2026 6:07 AM - SEC Filing
PharmaCorp Announces Fourth Quarter and Fiscal Year 2025 Financial Results
April 29, 2026 8:51 PM - Globe NewsWire
Form DEFA14A Pacira BioSciences, Inc.
April 28, 2026 4:22 PM - SEC Filing
Form ARS Pacira BioSciences, Inc. For: Dec 31
April 28, 2026 4:20 PM - SEC Filing
Pacira BioSciences Files Definitive Proxy Materials and Mails Letter to Shareholders
April 28, 2026 4:20 PM - StreetInsider
Form DEFC14A Pacira BioSciences, Inc. Filed by: Pacira BioSciences, Inc.
April 28, 2026 4:18 PM - SEC Filing
Real-World Data on EXPAREL® Shows Reduced Opioid Use and Lower Total Medical Costs in Medicare Patients Undergoing Total Hip Arthroplasty
April 27, 2026 8:00 AM - Globe NewsWire
Form 4 Pacira BioSciences, Inc. For: Apr 23 Filed by: Cross Shawn
April 24, 2026 8:41 PM - SEC Filing
Form 144 Pacira BioSciences, Inc. Filed by: Cross Shawn
April 23, 2026 7:23 PM - SEC Filing
Form 4 Pacira BioSciences, Inc. For: Apr 20 Filed by: Cross Shawn
April 22, 2026 8:03 PM - SEC Filing
Form 144 Pacira BioSciences, Inc. Filed by: Cross Shawn
April 22, 2026 4:20 PM - SEC Filing
Form 144 Pacira BioSciences, Inc. Filed by: Cross Shawn
April 21, 2026 4:21 PM - SEC Filing
Form 144 Pacira BioSciences, Inc. Filed by: Cross Shawn
April 20, 2026 4:12 PM - SEC Filing
Form PREC14A Pacira BioSciences, Inc. Filed by: Pacira BioSciences, Inc.
April 17, 2026 4:17 PM - SEC Filing
Pacira to Report First Quarter 2026 Financial Results on Thursday April 30, 2026
April 16, 2026 11:42 AM - Globe NewsWire
Pacira to Report First Quarter 2026 Financial Results on Thursday April 30, 2026
April 16, 2026 8:00 AM - StreetInsider
PharmaCorp Announces Investor Relations Agreement
April 13, 2026 1:22 PM - Globe NewsWire
Pacira Presents Real-World Data on EXPAREL® Showing Lower Total Healthcare Costs in Outpatient Total Hip and Knee Arthroplasty Procedures
April 13, 2026 8:00 AM - Globe NewsWire
Form SCHEDULE 13G Pacira BioSciences, Inc. Filed by: DIMENSIONAL FUND ADVISORS LP
April 9, 2026 1:44 PM - SEC Filing
Pacira BioSciences to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
April 8, 2026 8:00 AM - Globe NewsWire
PharmaCorp Rx Inc. To Present At The 2026 Bloom Burton & Co. Healthcare Investor Conference
April 2, 2026 5:00 PM - Globe NewsWire
Pacira BioSciences to Present Real-World Data on EXPAREL® Showing Reduced Cost of Care at Orthopaedic Research Society 2026 Annual Meeting
March 30, 2026 8:00 AM - StreetInsider
Form SCHEDULE 13G/A Pacira BioSciences, Inc. Filed by: VANGUARD GROUP INC
March 27, 2026 11:22 AM - SEC Filing
Pacira Pharmaceuticals (PCRX) PT Lowered to $25 at Barclays
March 26, 2026 2:20 AM - StreetInsider
Form 4/A Pacira BioSciences, Inc. For: Jun 11 Filed by: Kronenfeld Mark A.
March 19, 2026 5:43 PM - SEC Filing
Form 4 Pacira BioSciences, Inc. For: Mar 17 Filed by: Froimson Mark
March 19, 2026 5:43 PM - SEC Filing
Form 4 Pacira BioSciences, Inc. For: Mar 17 Filed by: SLONIN JONATHAN
March 19, 2026 5:43 PM - SEC Filing
Form 144 Pacira BioSciences, Inc. Filed by: Froimson Mark
March 17, 2026 2:55 PM - SEC Filing
Form 144 Pacira BioSciences, Inc. Filed by: SLONIN JONATHAN
March 17, 2026 11:12 AM - SEC Filing
Form SCHEDULE 13D/A Pacira BioSciences, Inc. Filed by: Doma Perpetual Capital Management LLC
March 12, 2026 7:58 PM - SEC Filing
Form DFAN14A Pacira BioSciences, Inc. Filed by: Doma Perpetual Capital Management LLC
March 12, 2026 9:19 AM - SEC Filing
DOMA Perpetual nominates three directors to Pacira BioSciences board
March 12, 2026 8:24 AM - StreetInsider
DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc.
March 12, 2026 8:20 AM - PR NewsWire
Form DEFA14A Pacira BioSciences, Inc.
March 11, 2026 5:13 PM - SEC Filing
Pacira BioSciences responds to activist investor director nominees
March 11, 2026 5:04 PM - StreetInsider
Pacira BioSciences Reaffirms Commitment to Shareholder Value Creation
March 11, 2026 5:03 PM - StreetInsider
Form DFAN14A Pacira BioSciences, Inc. Filed by: Doma Perpetual Capital Management LLC
March 11, 2026 3:26 PM - SEC Filing
DOMA Perpetual nominates three directors for Pacira BioSciences board
March 11, 2026 1:07 PM - StreetInsider
DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc.
March 11, 2026 1:06 PM - PR NewsWire
Full Article List
